Related Experiment Videos
Cytokines as a stressor: implications for depressive illness
Hymie Anisman1, Shawn Hayley, Nicolas Turrin
1Institute of Neuroscience, Carleton University, Ottawa, Ontario, Canada. hanisman@ccs.carleton.ca
The International Journal of Neuropsychopharmacology
|December 6, 2002
Summary
Immune system activation, particularly through cytokines like interleukin-1beta (IL-1beta), may contribute to depression by altering brain chemistry. Repeated exposure to these immune signals can amplify their effects, impacting emotional regulation.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Psychological stress is linked to depression.
- Immune system activation, via cytokines, causes neuroendocrine and neurochemical changes similar to stress.
- This suggests a role for immune activation in affective disorders.
Purpose of the Study:
- To review the neurochemical effects of interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and IL-2.
- To explore interactions between cytokines and psychogenic stressors.
- To discuss the sensitizing effects of repeated cytokine exposure.
Main Methods:
- Review of existing literature on cytokine administration and neurochemical changes.
- Analysis of synergistic effects and interactions with stressors.
- Discussion of time-dependent effects and sensitization.
Main Results:
- Cytokines (IL-1beta, TNF-alpha, IL-2) induce significant neurochemical alterations.
- Cytokine treatments can interact with psychogenic stressors.
- Repeated cytokine exposure leads to augmented neurochemical responses (sensitization).
Conclusions:
- Cytokines affect neurochemistry in brain regions involved in emotion, including the hypothalamus and limbic system.
- Cytokine-induced neurochemical changes may contribute to emotional disturbances, such as depression.
- Immune activation represents a potential pathway to understanding and treating affective illnesses.